Representational image
Representational image

Recently, the human trials for one of the most promising COVID-19 vaccine candidates had hit a stumbling block a participant developed an "unexplained illness", prompting the trials to be temporarily paused. Now, reports say that the trials are being resumed.

As per a Bloomberg report, a UK trial of the experimental vaccine has been restarted. The vaccine is being developed by British-Swedish pharmaceutical company AstraZeneca and the University of Oxford and had recently entered Phase 3 of human testing.

(To download our E-paper please click here. The publishers permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Free Press Journal